Short-term changes in des-acyl ghrelin following bariatric surgery.

Area of Science:

• Metabolic surgery research
• Endocrinology of obesity
• Physiological effects of bariatric procedures

Background:

• Bariatric surgery significantly impacts physiological systems, including the regulation of des-acyl ghrelin (DAG).
• Previous research indicates a negative association between DAG levels and excess adiposity and insulin resistance.

Purpose of the Study:

• To investigate the relationship between serum DAG concentrations and short-term weight loss after bariatric surgery.
• To explore DAG's role as a potential marker for adiposity and metabolic response post-surgery.

Main Methods:

• Prospective cohort study involving 62 patients across three bariatric surgery centers.
• Fasting blood samples for DAG measurement were collected preoperatively, 2 days postoperatively, and at 3 months.
• Anthropometric and laboratory assessments were conducted concurrently with blood sampling.

Main Results:

• DAG concentrations showed significant inverse correlations with preoperative weight, BMI, and excess weight (P < 0.05).
• These associations were more pronounced and persistent in Roux-en-Y gastric bypass (RYGB) patients compared to sleeve gastrectomy (SG) patients.
• No significant relationship was found between DAG and relative weight-loss metrics; DAG levels were higher in females.

Conclusions:

• Serum DAG levels are inversely associated with absolute measures of adiposity, particularly in RYGB patients.
• Findings support DAG's potential utility as a marker for total body fat and early postoperative metabolic changes.
• DAG may serve as a valuable indicator in monitoring patient response to bariatric interventions.